UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion

Cancer research (Chicago, Ill.), 2020-10, Vol.80 (19), p.4129-4144

2020

Volltextzugriff (PDF)

Blockade of KCa3.1 Ameliorates Renal Fibrosis Through the TGF-β1/Smad Pathway in Diabetic Mice

Diabetes (New York, N.Y.), 2013-08, Vol.62 (8), p.2923-2934

2013

Volltextzugriff (PDF)

Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice

PloS one, 2014-11, Vol.9 (11), p.e108994

2014

Volltextzugriff (PDF)

MiRNA-200b represses transforming growth factor-β1-induced EMT and fibronectin expression in kidney proximal tubular cells

American journal of physiology. Renal physiology, 2013-05, Vol.304 (10), p.F1266-F1273

2013

Volltextzugriff (PDF)

Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG

Cell reports (Cambridge), 2021-04, Vol.35 (2), p.108994-108994, Article 108994

2021

Volltextzugriff (PDF)

Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells

PloS one, 2009-07, Vol.4 (7), p.e6461-e6461

2009

Volltextzugriff (PDF)

Plumbagin ameliorates diabetic nephropathy via interruption of pathways that include NOX4 signalling

PloS one, 2013-08, Vol.8 (8), p.e73428-e73428

2013

Volltextzugriff (PDF)

GSK3 inhibition prevents lethal GVHD in mice

Experimental hematology, 2013, Vol.41 (1), p.39-55.e10

2013

Volltextzugriff (PDF)

Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success

Virology journal, 2009-10, Vol.6 (1), p.184-184, Article 184

2009

Volltextzugriff (PDF)

96 shRNAs designed for maximal coverage of HIV-1 variants

Retrovirology, 2009-06, Vol.6 (55), p.55-55, Article 55

2009

Volltextzugriff (PDF)

Increasing Stem Cell Dose Promotes Posttransplant Immune Reconstitution

Stem cells and development, 2017-04, Vol.26 (7), p.461

2017

Volltextzugriff (PDF)

Abstract 3224: Copper homeostasis: A new player in anti-tumor immune response

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3224-3224

2019

Volltextzugriff (PDF)

The role of IRF1 and IRF2 transcription factors in leukaemogenesis

Current gene therapy, 2006-10, Vol.6 (5), p.543

2006

Volltextzugriff (PDF)

Genome-Wide CRISPR-Cas9 Screening Identifies a Synergy between Hypomethylating Agents and Sumoylation Blockade in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Blood, 2022-11, Vol.140 (Supplement 1), p.220-221

2022

Volltextzugriff (PDF)

Mutant N- ras preferentially drives human CD34 + hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouse

Experimental hematology, 2004-09, Vol.32 (9), p.852-860

2004

Volltextzugriff (PDF)

Abstract 3760: Preclinical optimization of a low cost PiggyBac transposase (PB) generated CD19-specific chimeric antigen receptor T cell (CART19) product for a first in man trial using local hospital cell manufacture

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3760-3760

2017

Volltextzugriff (PDF)

Stem Cell Approach to Generate Chimeric Antigen Receptor Modified Immune Effector Cells to Treat Cancer

Blood, 2014-12, Vol.124 (21), p.2437-2437

2014

Volltextzugriff (PDF)

Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia

Science translational medicine, 2023-05, Vol.15 (696), p.eabm1262

2023

Volltextzugriff (PDF)

KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis

Nephrology, dialysis, transplantation, 2014-02, Vol.29 (2), p.313-324

2014

Volltextzugriff (PDF)

Declined presentation T-cell precursors to generate chimeric antigen receptor (CAR)-modified t cells

Experimental hematology, 2015-09, Vol.43 (9), p.S60-S60

2015

Volltextzugriff (PDF)

Declined presentation stem cell approach to generate chimeric antigen receptor modified immune effector cells

Experimental hematology, 2015-09, Vol.43 (9), p.S59-S59

2015

Volltextzugriff (PDF)

Declined presentation one dose of 5-AZA-2'-Deoxycytidine enhances therapeutic efficacy of cart-cell therapy in a murine model by improving T-cell persistence

Experimental hematology, 2015-09, Vol.43 (9), p.S59-S59

2015

Volltextzugriff (PDF)

Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia

Experimental hematology, 2015-12, Vol.43 (12), p.1001-1014.e5

2015

Volltextzugriff (PDF)

Comparative Analysis of Genome-Scale Gene Regulatory Networks in Human Hematopoietic Stem and Myeloid Progenitor Fractions

BLOOD, 2022-11, Vol.140 (Supplement 1), p.2846-2848

2022

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion

Blockade of KCa3.1 Ameliorates Renal Fibrosis Through the TGF-β1/Smad Pathway in Diabetic Mice

Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice

MiRNA-200b represses transforming growth factor-β1-induced EMT and fibronectin expression in kidney proximal tubular cells

Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG

Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells

Plumbagin ameliorates diabetic nephropathy via interruption of pathways that include NOX4 signalling

GSK3 inhibition prevents lethal GVHD in mice

Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success

96 shRNAs designed for maximal coverage of HIV-1 variants

Increasing Stem Cell Dose Promotes Posttransplant Immune Reconstitution

Abstract 3224: Copper homeostasis: A new player in anti-tumor immune response

The role of IRF1 and IRF2 transcription factors in leukaemogenesis

Genome-Wide CRISPR-Cas9 Screening Identifies a Synergy between Hypomethylating Agents and Sumoylation Blockade in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Genome-wide transcription factor-binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs

Mutant N- ras preferentially drives human CD34 + hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouse

Abstract 3760: Preclinical optimization of a low cost PiggyBac transposase (PB) generated CD19-specific chimeric antigen receptor T cell (CART19) product for a first in man trial using local hospital cell manufacture

Stem Cell Approach to Generate Chimeric Antigen Receptor Modified Immune Effector Cells to Treat Cancer

Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia

KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis

Declined presentation T-cell precursors to generate chimeric antigen receptor (CAR)-modified t cells

Declined presentation stem cell approach to generate chimeric antigen receptor modified immune effector cells

Declined presentation one dose of 5-AZA-2'-Deoxycytidine enhances therapeutic efficacy of cart-cell therapy in a murine model by improving T-cell persistence

Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia

Comparative Analysis of Genome-Scale Gene Regulatory Networks in Human Hematopoietic Stem and Myeloid Progenitor Fractions

Suchergebnisse filtern